Alginate and DNA gels are suitable delivery systems for diabetic wound healing

International Journal of Lower Extremity Wounds

Volumn 14, Issue 2, 2015, Pages 146-153

  Tellechea, Ana ^a,b   Silva, Eduardo A ^c   Min, Jianghong ^a,d   Leal, Ermelindo C ^a,b   Auster, Michael E ^a   Pradhan Nabzdyk, Leena ^a   Shih, William ^a,d   Mooney, David J ^d,e   Veves, Aristidis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c University of California Davis   (United States)

^d HARVARD UNIVERSITY   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

biomaterials; diabetic foot ulcers; endothelial precursor cells; neuropeptides; wound healing

Indexed keywords

ALGINIC ACID; DNA; NEUROTENSIN; SUBSTANCE P; VASCULOTROPIN; BIOMATERIAL; DRUG CARRIER; GEL; GLUCURONIC ACID; HEXURONIC ACID; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC WOUND HEALING; DRUG DELIVERY SYSTEM; DRUG EFFECT; EFFECTOR CELL; ENDOTHELIUM CELL; HYDROGEL; LIMB ISCHEMIA; MOUSE; NONHUMAN; OUTGROWTH ENDOTHELIAL CELL; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; UMBILICAL CORD; VALIDATION STUDY; WOUND HEALING; ANIMAL; BANDAGE; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC FOOT; DRUG EFFECTS; GEL;

ALGINATES; ANIMALS; BANDAGES; BIOCOMPATIBLE MATERIALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC FOOT; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; GLUCURONIC ACID; HEXURONIC ACIDS; MICE; MICE, INBRED C57BL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84937551409     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734615580018     Document Type: Article

References (30)

1. American Diabetes Association. Diabetes 1996: Vital Statistics. In: Cowie CC, Eberhardt MS, eds. Alexandria, VA: American Diabetes Association; 1996.
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J,. The global burden of diabetic foot disease. Lancet. 2005; 366: 1719-1724.
3. Wieman TJ, Smiell JM, Su Y,. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998; 21: 822-827.
4. Marston WA, Hanft J, Norwood P, Pollak R,. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003; 26: 1701-1705.
5. Veves A, Falanga V, Armstrong DG, Sabolinski ML,. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001; 24: 290-295.
6. Tellechea A, Kafanas A, Leal EC,. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds. 2013; 12: 4-11.
7. Pradhan Nabzdyk L, Kuchibhotla S, Guthrie P,. Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg. 2013; 58: 766-775.e12.
8. Dinh T, Tecilazich F, Kafanas A,. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012; 61: 2937-2947.
9. Leal EC, Carvalho E, Tellechea A,. Impaired wound healing in diabetes through substance P-dependent mechanism. Wound Repair Regen. 2012; 20 (2): A28.
10. Moura LI, Dias AM, Suesca E,. Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice. Biochim Biophys Acta. 2014; 1842: 32-43.
11. Moura LI, Dias AM, Leal EC, Carvalho L, de Sousa HC, Carvalho E,. Chitosan-based dressings loaded with neurotensin-an efficient strategy to improve early diabetic wound healing. Acta Biomater. 2014; 10: 843-857.
12. Tecilazich F, Dinh T, Pradhan-Nabzdyk L,. Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One. 2013; 8: e83314.
13. Pedroso DC, Tellechea A, Moura L,. Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells. PLoS One. 2011; 6: e16114.
14. Silva EA, Kim ES, Kong HJ, Mooney DJ,. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A. 2008; 105: 14347-14352.
15. Kearney CJ, Mooney DJ,. Macroscale delivery systems for molecular and cellular payloads. Nat Mater. 2013; 12: 1004-1017.
16. Sweitzer SM, Fann SA, Borg TK, Baynes JW, Yost MJ,. What is the future of diabetic wound care? Diabetes Educ. 2006; 32: 197-210.
17. Baraniak PR, McDevitt TC,. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010; 5: 121-143.
18. Chen L, Xu Y, Zhao J,. Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One. 2014; 9: e96161.
19. Nauta A, Seidel C, Deveza L,. Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing. Mol Ther. 2013; 21: 445-455.
20. Bencherif SA, Sands RW, Bhatta D,. Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci U S A. 2012; 109: 19590-19595.
21. Silva EA, Mooney DJ,. Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials. 2010; 31: 1235-1241.
22. Borselli C, Cezar CA, Shvartsman D, Vandenburgh HH, Mooney DJ,. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials. 2011; 32: 8905-8914.
23. Hill E, Boontheekul T, Mooney DJ,. Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A. 2006; 103: 2494-2499.
24. Lee KY, Mooney DJ,. Alginate: properties and biomedical applications. Prog Polym Sci. 2012; 37: 106-126.
25. Silva EA, Mooney DJ,. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost. 2007; 5: 590-598.
26. Xing Y, Cheng E, Yang Y,. Self-assembled DNA hydrogels with designable thermal and enzymatic responsiveness. Adv Mater. 2011; 23: 1117-1121.
27. Michaels J 5th, Dobryansky M, Galiano RD,. Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. Wound Repair Regen. 2005; 13: 506-512.
28. Galiano RD, Tepper OM, Pelo CR,. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol. 2004; 164: 1935-1947.
29. Douglas SM, Bachelet I, Church GM,. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 2012; 335: 831-834.
30. Ke Y, Ong LL, Shih WM, Yin P,. Three-dimensional structures self-assembled from DNA bricks. Science. 2012; 338: 1177-1183.